Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The "Cerebrospinal Fluid Management Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.
The global cerebrospinal fluid management market is poised for significant growth, with an expected valuation of US$ 2,892.54 million by 2030, up from US$ 1,911.37 million in 2022. This growth is estimated to record a Compound Annual Growth Rate (CAGR) of 5.3% from 2022 to 2030.
Key Market Insights
Key insights from the report include:
- The global cerebrospinal fluid management market is projected to reach US$ 2,892.54 million by 2030, demonstrating a CAGR of 5.3% during the forecast period.
- Recent product developments in the CSF management market, such as the ReFlow System Mini by Anuncia Medical Inc., have contributed to market growth.
- Growing demand for better treatment modalities and the increasing use of CSF parameters as biomarkers for neurological disorders are driving the market's expansion.
Rising Demand for Better Treatment Modalities
The growing demand for better treatment modalities has led to advancements in products related to cerebrospinal fluid management. For instance, in September 2022, Anuncia Medical Inc. received approval from the US Food and Drug Administration (FDA) for its ReFlow System Mini, a noninvasive device designed for the treatment of patients with hydrocephalus and other cerebrospinal fluid disorders. This product development illustrates the industry's commitment to improving patient care.
Use of CSF Parameters in Neurological Disease Diagnosis
Cerebrospinal fluid (CSF) parameters have gained importance as biomarkers for neurological disorders in adults. Circulating microRNAs in CSF are considered promising biomarkers for diagnosing various neurological diseases, including Parkinson's Disease (PD) and Alzheimer's Disease (AD). As the prevalence of these diseases increases globally, there is a growing demand for CSF management products.
PD, for example, is a neurodegenerative disease that affects cognitive and motor functions. The World Health Organization (WHO) reported in 2022 that the prevalence of PD has doubled in the last 25 years, affecting approximately 1% of the global population aged over 60. Similarly, altered CSF parameters are observed in patients with seizures or epilepsy, leading to research and development activities for the use of CSF management products in treating these disorders.
Market Segmentation
The cerebrospinal fluid management market is segmented by product and end user. The key segments include:
- Product: CSF shunts (including ventriculoperitoneal shunts, ventriculoatrial shunts, ventriculopleural shunts, and lumboperitoneal shunts) and CSF drainage systems (including external ventricular drainage (EVD) systems and lumbar drainage (LD) systems).
- End User: The market serves various end users, including men, women, and children.
Geographical Landscape
The market is segmented by geographical landscape into North America, Europe, Asia Pacific, South America, and the Middle East and Africa. North America leads the market due to increasing incidences of hydrocephalus, traumatic brain injury, and other neurological conditions, along with rapid technological innovations. Asia Pacific is the fastest-growing region due to a growing geriatric population, demand for advanced medical devices, and expanding healthcare infrastructure.
Challenges and Growth Drivers
While the cerebrospinal fluid management market is experiencing growth, challenges such as the risk associated with CSF shunts are hindering market expansion. However, increasing demand for CSF management products, advancements in treatment modalities, and the use of CSF parameters as biomarkers for neurological diseases are key growth drivers.
Companies Mentioned
- Medtronic Plc
- Integra LifeSciences Holdings Corp
- B. Braun SE
- Argi Group Health Services Ltd Sti
- Sophysa SA
- BeckerSmith Medical Inc
- Delta Surgical Ltd
- Moller Medical GmbH
- Natus Medical Inc
- Spiegelberg GmbH & Co KG
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 177 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $1.91 Billion |
| Forecasted Market Value (USD) by 2030 | $2.89 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Cerebrospinal Fluid Management Market Landscape
5. Cerebrospinal Fluid Management Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidences of CSF Leak
5.1.2 Growing Developments for CSF Management Products
5.2 Market Restraints
5.2.1 Risk Associated with CSF Shunts
5.3 Market Opportunities
5.3.1 Increasing Focus on Use of CSF Management for Treatment of Neurological Diseases
5.4 Future Trends
5.4.1 Technological Developments for CSF Shunts
5.5 Impact Analysis:
6. Cerebrospinal Fluid Management Market - Global Market Analysis
7. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product
8. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User
9. Cerebrospinal Fluid Management Market - Geographical Analysis
10. Pre & Post Covid-19 Impact
11. Cerebrospinal Fluid Management Market -Industry Landscape
12. Company Profiles
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/x8qbeq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
